Compile Data Set for Download or QSAR
Report error Found 120 Enz. Inhib. hit(s) with all data for entry = 13114
Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760011(US20250236613, Compound 24)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760008(US20250236613, Compound 21)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760009(US20250236613, Compound 22)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760007(US20250236613, Compound 20)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760004(US20250236613, Compound 17)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760018(US20250236613, Compound 31)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760019(US20250236613, Compound 32)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760016(US20250236613, Compound 29)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760015(US20250236613, Compound 28)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760012(US20250236613, Compound 25)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760027(US20250236613, Compound 40)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760023(US20250236613, Compound 36)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760034(US20250236613, Compound 47)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760031(US20250236613, Compound 44)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760028(US20250236613, Compound 41)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760029(US20250236613, Compound 42)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760038(US20250236613, Compound 51)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760054(US20250236613, Compound 63)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760055(US20250236613, Compound 64)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760053(US20250236613, Compound 62)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760050(US20250236613, Compound 59)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760051(US20250236613, Compound 60)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760059(US20250236613, Compound 68)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760074(US20250236613, Compound 79)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760075(US20250236613, Compound 80)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760070(US20250236613, Compound 75)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760071(US20250236613, Compound 76)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760066(US20250236613, Compound 73)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760084(US20250236613, Compound 87)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760087(US20250236613, Compound 88)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760083(US20250236613, Compound 86)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760078(US20250236613, Compound 83)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760081(US20250236613, Compound 84)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760076(US20250236613, Compound 81)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760096(US20250236613, Compound 95)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760097(US20250236613, Compound 96)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760095(US20250236613, Compound 94)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760093(US20250236613, Compound 92)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760090(US20250236613, Compound 89)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760091(US20250236613, Compound 90)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760104(US20250236613, Compound 103)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760105(US20250236613, Compound 104)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760102(US20250236613, Compound 101)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760103(US20250236613, Compound 102)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760100(US20250236613, Compound 99)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760101(US20250236613, Compound 100)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760098(US20250236613, Compound 97)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760099(US20250236613, Compound 98)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760112(US20250236613, Compound 111)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Targetsarm1(Human)
SIRONAX

US Patent
LigandPNGBDBM760113(US20250236613, Compound 112)
Affinity DataIC50: 0.100nMAssay Description:The enzymatic assay was performed in a 384-well plate using Dulbecco's PBS buffer as the reaction buffer. Purified SARM1 (50-724) with a final co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
11/5/2025
Entry Details
US Patent

Displayed 1 to 50 (of 120 total ) | Next | Last >>
Jump to: